140 Participants Needed

Choline Supplementation for Cannabis Use During Pregnancy

SH
MC
Overseen ByM. Camille Hoffman, MD
Age: 18 - 65
Sex: Female
Trial Phase: Phase 1
Sponsor: University of Colorado, Denver
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this study is to determine if providing a nutritional supplement, phosphatidylcholine, to pregnant women who have used cannabis products during the current pregnancy improves the offspring\'s brain-related development during the first 3 months. Participating pregnant women will receive either phosphatidylcholine or a placebo from approximately 16 weeks gestation through birth. The primary outcomes are the child\'s brain responses to sound at 4 weeks corrected age and infant behaviors at 3 months corrected age as reported by the primary caregiver. Secondary outcomes include motor, socio-emotional, language and cognitive development.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is choline supplementation safe for pregnant women?

Choline supplementation during pregnancy is generally considered safe and is important for fetal brain development. Studies suggest that higher maternal choline intake is associated with better child neurocognition and may reduce the risk of neural tube defects.12345

How does choline supplementation differ from other treatments for cannabis use during pregnancy?

Choline supplementation is unique because it is a non-drug treatment that focuses on providing an essential nutrient to support fetal brain development and improve cognitive outcomes in children, rather than directly addressing cannabis use. Unlike other treatments, it involves increasing the intake of choline, which is often below recommended levels in pregnant women, to meet the increased demands during pregnancy.12367

Research Team

SH

Sharon Hunter, PhD

Principal Investigator

University of Colorado School of Medicine

MC

M. Camille Hoffman, MD

Principal Investigator

University of Colorado, Denver

Eligibility Criteria

This trial is for pregnant women who have used cannabis during their current pregnancy. It aims to see if a nutritional supplement, phosphatidylcholine, can improve their baby's brain development in the first 18 months after birth.

Inclusion Criteria

Pregnant women who report cannabis use during current pregnancy

Exclusion Criteria

Pregnancies complicated by fetal anomaly, including neural tube defect or chromosomal abnormality, or multiple gestations due to increased obstetrical risks
I have significant health issues unrelated to my pregnancy.
Evidence of noncompliance
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either phosphatidylcholine or placebo from approximately 16 weeks gestation through birth

Approximately 24 weeks
Visits at enrollment, and approximately at weeks 16, 22, 28, 34

Follow-up

Participants are monitored for safety and effectiveness after treatment

3 months
Assessments at 1 month and 3 months corrected age

Treatment Details

Interventions

  • Choline
Trial Overview The study tests whether taking phosphatidylcholine from about 16 weeks of pregnancy until birth affects the child's early brain responses and behaviors at various stages up to 18 months old, compared with a placebo.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: PhosphatidylcholineActive Control1 Intervention
Participants will take 8 900mg capsules of phosphatidylcholine every day, the equivalent of approximately 1028 mg of choline per day until delivery
Group II: PlaceboPlacebo Group1 Intervention
Participants will take 8 placebo capsules each containing 1100mg Rice Bran Oil and 150mg Pumpkin Seed Oil every day in place of phosphatidylcholine supplement.

Choline is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Choline for:
  • Dietary supplement
🇪🇺
Approved in European Union as Choline for:
  • Dietary supplement
🇨🇦
Approved in Canada as Choline for:
  • Dietary supplement

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+

Findings from Research

In a pilot study of 16 pregnant women in Jamaica, the average dietary choline intake was found to be significantly below the recommended level of 450 mg/day, with a mean intake of only 278.5 mg.
The mean plasma choline concentration in these women was 8.4 micromol/L, which is lower than the normal levels for both non-pregnant individuals and pregnant women, suggesting potential nutritional inadequacy that could affect fetal development.
Dietary intake of choline and plasma choline concentrations in pregnant women in Jamaica.Gossell-Williams, M., Fletcher, H., McFarlane-Anderson, N., et al.[2022]
Choline supplementation during pregnancy has been shown to improve cognitive outcomes in children, highlighting its importance as a non-pharmacological intervention for enhancing child development.
This systematic review analyzed 9 studies on various forms of choline supplementation (like choline chloride and phosphatidylcholine) and confirmed its effectiveness in promoting better cognitive abilities in offspring.
[Importance of choline during pregnancy and lactation: A systematic review].Heras-Sola, J., Gallo-Vallejo, JL.[2023]
Betaine supplementation did not effectively increase serum choline levels in non-pregnant women, whether given as a single dose or over a week, indicating it cannot replace phosphatidylcholine for boosting choline levels.
In contrast, phosphatidylcholine supplements significantly raised serum choline concentrations after both single and repeated doses, confirming their efficacy in increasing choline levels essential for fetal brain development.
Effects of phosphatidylcholine and betaine supplements on women's serum choline.Hoffman, MC., Olincy, A., D'Alessandro, A., et al.[2022]

References

Dietary intake of choline and plasma choline concentrations in pregnant women in Jamaica. [2022]
[Importance of choline during pregnancy and lactation: A systematic review]. [2023]
Effects of phosphatidylcholine and betaine supplements on women's serum choline. [2022]
Choline Content of Term and Preterm Infant Formulae Compared to Expressed Breast Milk-How Do We Justify the Discrepancies? [2021]
Association between Maternal Choline, Fetal Brain Development, and Child Neurocognition: Systematic Review and Meta-Analysis of Human Studies. [2023]
Choline metabolome response to prenatal choline supplementation across pregnancy: A randomized controlled trial. [2022]
Choline: Exploring the Growing Science on Its Benefits for Moms and Babies. [2020]